Holen Sie sich die Stockscreener-App
3.17
3.35%
-0.11
Trxade Health Inc Aktie (MEDS) Neueste Nachrichten
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC. - Stock Titan
SCNXScienture Holdings Inc Stock Price and Quote - Finviz
Trxade Health announces name change to Scienture Holdings - Intellectia AI
MEDS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - Intellectia AI
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - Intellectia AI
MEDS Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
MEDS News & Events - Intellectia AI
MEDSTRxADE HEALTH, Inc. Latest Stock News & Market Updates - Stock Titan
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value - Quantisnow
SCIENTURE Appoint Dr. Shankar Hariharan and Dr. Narasimhan Mani as Co-CEO’s - citybiz
Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC - ACCESS Newswire
TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC. - ACCESS Newswire
Wellgistics Health (MEDS) Stock Price, News & Analysis - Stock Titan
Bonum Health(TM), LLC (a TRxADE HEALTH Company) Reaffirms its Commitment to Independent Pharmacies and Group Purchasing Organizations (GPOs) with its Novel Telemedicine Services Model - ACCESS Newswire
Oragenics Appoints Janet Huffman As Interim CEO - citybiz
Urgent Company Parent Co. Sued By Eat Well Investment Group - Nosh.com
Group Alleges $10M 'Sham' In Fla. Plant-Based Co. Stock Deal - Law360
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
MEDS Price History for Trxade Health Stock - Barchart.com
Trxade Health (MEDS) Q2 2024 Research Summary - AlphaStreet
About Us - FinancialContent
Dykema Guides TRxADE in Another Acquisition - Dykema
Tampa pharma company stacked with former McKesson execs launches IPO - The Business Journals
TRxADE HEALTH (MEDS) Stock News & Updates - Stock Titan
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary - AlphaStreet
TRxADE Health, Inc. Announces Special Cash Dividend - Stock Titan
Why Is Trxade Health (MEDS) Stock Up 230% Today? - InvestorPlace
Dykema Completes Sale of Assets for TRxADE Health, Inc. - Dykema
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results - AlphaStreet
Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry. - Yahoo Finance
Food technology company prepares to enter plant-based pet nutrition market - Pet Food Processing
Trxade Health (MEDS) Stock Is Moving Higher: What's Going On? - Benzinga
Trxade Health Inc. (NASDAQ: MEDS) Q2 2023 Research Summary - AlphaStreet
Artemis Strategic (ARTE) to Combine with Danam Health in $200M Deal - SPACInsider
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc. - GlobeNewswire
Trxade Health up 68%this time it’s a real price movement on a reverse takeover - Dhaka Tribune
Superlatus, Inc. to Combine with TRxADE HEALTH, Inc., to Create a Global Food Consolidation Platform - GlobeNewswire
Trxade Health, MEDS, is up 1,506% or 7%, take your pick - Dhaka Tribune
TRxADE HEALTH, Inc. (NASDAQ:MEDS) Q1 2023 Earnings Call Transcript - Insider Monkey
MEDS Earnings: Trxade Health’s net loss narrows in Q1 2023; revenue down 31% - AlphaStreet
Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu - AlphaStreet
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows - AlphaStreet
Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary - AlphaStreet
Trxade explores alternative ways to find partners for B2C assets: CEO Suren Ajjarapu - AlphaStreet
Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows - AlphaStreet
Bonum Health™, LLC (a TRxADE HEALTH Company) Strikes Strategic Business-to-Business (B2B) Telemedicine Services Agreement with Insurance Brokerage Firm(s) for Small-to-Medium Business (SMB) Employer Groups - Yahoo Finance
Trxade Health, Inc. Appoints Mr. Jeff Newell to Its Board of Directors, Member of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee - marketscreener.com
TRxADE HEALTH, Inc., Launches NEXT DAY Delivery Services Via TRxADE Prime Plus Program - Yahoo Finance
TRxADE HEALTH Announces Termination of Public Offering of Common Stock - Yahoo Finance
MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth - AlphaStreet
TRxADE (MEDS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
User - The Chronicle-Journal
Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu - AlphaStreet
Bonum Health(TM) (TRxADE HEALTH Company) Launches Veterinary Telemedicine Services - FinancialContent
Daily Breeze - FinancialContent
Trxade Health Inc. (NASDAQ: MEDS) Q4 2021 Research Summary - AlphaStreet News
Trxade CEO Suren Ajjarapu: Will see the impact of GPO program by Q3 next year - AlphaStreet
Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary - AlphaStreet
Southeastern Grocers Expands Telehealth Offerings - Progressive Grocer
Trxade Group (MEDS) Stock Live Price, Chart & News - CoinCodex
Trxade Group to Postpone Virtual Roadshow Presentation - GlobeNewswire
CEO TALKS: The story of Trxade Group (MEDS) - AlphaStreet
MEDS Forecast, Price Target & Analyst Ratings | TRXADE HEALTH INC (NASDAQ:MEDS) - ChartMill
MEDS Stock Price, Quote & Chart | TRXADE HEALTH INC (NASDAQ:MEDS) - ChartMill
TRxADE Group to Present at the Diamond Equity Research Emerging Growth Invitational - GlobeNewswire
TRxADE Group to Present at the Virtual Fall Investor Summit - GlobeNewswire
SingleCare deal aimed at growing subscribers: Trxade CEO Suren Ajjarapu - AlphaStreet
Trxade Group Reports Record Third Quarter 2020 Financial Results - GlobeNewswire
Trxade Group to Report Third Quarter 2020 Results on Monday, October 26th at 5:00 p.m. Eastern Time - GlobeNewswire
No concerns on margin side: Trxade (MEDS) CEO Suren Ajjarapu - AlphaStreet
Trxade Group Inc. (MEDS) Q2 2020 Earnings Call Transcript - AlphaStreet
Trxade Group Announces Addition to the Russell MicroCap Index - GlobeNewswire
Trxade (MEDS) aims to take on pharmacy chains with an alternate online network - AlphaStreet
Tampa area health tech company rings Nasdaq opening bell - St Pete Catalyst
Trxade Group, Inc. Discusses Seven Consecutive Quarters of Revenue Growth, Provides Operational Progress - GlobeNewswire
Coverage Initiated for Trxade Group Inc. via NetworkNewsWire - GlobeNewswire
0.56%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):